Parametric Portfolio Associates’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-87,400
| Closed | -$2.56M | – | 3988 |
|
|
2017
Q3 | $2.56M | Buy |
87,400
+2,775
| +3% | +$77.7K | ﹤0.01% | 2407 |
|
|
2017
Q2 | $2.22M | Buy |
84,625
+10,775
| +15% | +$265K | ﹤0.01% | 2462 |
|
|
2017
Q1 | $1.73M | Buy |
73,850
+2,422
| +3% | +$59.8K | ﹤0.01% | 2547 |
|
|
2016
Q4 | $1.8M | Sell |
71,428
-56,587
| -44% | -$1.43M | ﹤0.01% | 2441 |
|
|
2016
Q3 | $3.59M | Sell |
128,015
-36,453
| -22% | -$934K | 0.01% | 1874 |
|
|
2016
Q2 | $4.06M | Sell |
164,468
-24,059
| -13% | -$597K | 0.01% | 1720 |
|
|
2016
Q1 | $4.17M | Buy |
188,527
+29,383
| +18% | +$782K | 0.01% | 1762 |
|
|
2015
Q4 | $5.57M | Buy |
159,144
+3,577
| +2% | +$112K | 0.01% | 1270 |
|
|
2015
Q3 | $4.43M | Sell |
155,567
-16,519
| -10% | -$555K | 0.01% | 1217 |
|
|
2015
Q2 | $5.73M | Sell |
172,086
-43,983
| -20% | -$1.35M | 0.01% | 1205 |
|
|
2015
Q1 | $6.09M | Sell |
216,069
-7,550
| -3% | -$188K | 0.01% | 1123 |
|
|
2014
Q4 | $4.63M | Sell |
223,619
-1,394
| -0.6% | -$33.1K | 0.01% | 1322 |
|
|
2014
Q3 | $5.5M | Buy |
225,013
+14,343
| +7% | +$380K | 0.01% | 1122 |
|
|
2014
Q2 | $6.02M | Buy |
210,670
+16,883
| +9% | +$470K | 0.01% | 1040 |
|
|
2014
Q1 | $5.42M | Buy |
193,787
+11,191
| +6% | +$275K | 0.01% | 1081 |
|
|
2013
Q4 | $3.93M | Buy |
182,596
+23,054
| +14% | +$419K | 0.01% | 1312 |
|
|
2013
Q3 | $2.12M | Buy |
159,542
+22,483
| +16% | +$303K | 0.01% | 1891 |
|
|
2013
Q2 | $1.9M | Buy |
+137,059
| New | +$1.94M | 0.01% | 1864 |
|
Parametric Portfolio Associates's PMC Position: Q4 2017 in Review
Parametric Portfolio Associates sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 87,400 shares — an estimated $2.56M sold.
Parametric Portfolio Associates first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $6.09M in Q1 2015. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- Parametric Portfolio Associates reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- Parametric Portfolio Associates sold 87,400 PharMerica Corporation shares in Q4 2017, an estimated $2.56M.
- Parametric Portfolio Associates first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- Parametric Portfolio Associates's PharMerica Corporation position peaked at $6.09M in Q1 2015.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on Parametric Portfolio Associates's 13F filing for Q4 2017, filed 14 Feb 2018.